237 related articles for article (PubMed ID: 36082872)
1. The Resilience of
Juárez-López D; Morales-Ruiz E; Herrera-Zúñiga LD; González-Carrera Z; Cuevas-Reyes E; Corzo G; Schcolnik-Cabrera A; Villegas E
Curr Med Chem; 2022; 30(1):72-103. PubMed ID: 36082872
[TBL] [Abstract][Full Text] [Related]
2.
Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L
Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302
[TBL] [Abstract][Full Text] [Related]
3. The Mechanism of Killing by the Proline-Rich Peptide Bac7(1-35) against Clinical Strains of Pseudomonas aeruginosa Differs from That against Other Gram-Negative Bacteria.
Runti G; Benincasa M; Giuffrida G; Devescovi G; Venturi V; Gennaro R; Scocchi M
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137800
[No Abstract] [Full Text] [Related]
4. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures.
Antunes B; Zanchi C; Johnston PR; Maron B; Witzany C; Regoes RR; Hayouka Z; Rolff J
PLoS Biol; 2024 Jul; 22(7):e3002692. PubMed ID: 38954678
[TBL] [Abstract][Full Text] [Related]
5. An in-vivo experimental evaluation of the efficacy of fish-derived antimicrobial peptides against multidrug-resistant
Al-Rasheed AA; Garba B; Handool KO; Al-Jashamy KA; Odhah MNA; Dirie NI; Daud HM
Pan Afr Med J; 2023; 46():112. PubMed ID: 38465008
[TBL] [Abstract][Full Text] [Related]
6. 'Targeting' the search: An upgraded structural and functional repository of antimicrobial peptides for biofilm studies (B-AMP v2.0) with a focus on biofilm protein targets.
Ravichandran S; Avatapalli S; Narasimhan Y; Kaushik KS; Yennamalli RM
Front Cell Infect Microbiol; 2022; 12():1020391. PubMed ID: 36329825
[TBL] [Abstract][Full Text] [Related]
7. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus.
Hincapié O; Giraldo P; Orduz S
Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331
[TBL] [Abstract][Full Text] [Related]
8. Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains.
Lin TT; Yang LY; Lin CY; Wang CT; Lai CW; Ko CF; Shih YH; Chen SH
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047760
[TBL] [Abstract][Full Text] [Related]
9. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
10. In Silico-Based Design of a Hybrid Peptide with Antimicrobial Activity against Multidrug-Resistant
Shin MK; Park HR; Hwang IW; Bu KB; Jang BY; Lee SH; Oh JW; Yoo JS; Sung JS
Toxins (Basel); 2023 Nov; 15(12):. PubMed ID: 38133172
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Activity and Stability of Short and Long Based Arachnid Synthetic Peptides in the Presence of Commercial Antibiotics.
Arenas I; Villegas E; Walls O; Barrios H; Rodríguez R; Corzo G
Molecules; 2016 Feb; 21(2):. PubMed ID: 26901176
[TBL] [Abstract][Full Text] [Related]
12. The Remarkable Innate Resistance of Burkholderia bacteria to Cationic Antimicrobial Peptides: Insights into the Mechanism of AMP Resistance.
Ghimire J; Guha S; Nelson BJ; Morici LA; Wimley WC
J Membr Biol; 2022 Oct; 255(4-5):503-511. PubMed ID: 35435452
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78.
Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC
Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
16. Highly Potent Antibacterial Organometallic Peptide Conjugates.
Albada B; Metzler-Nolte N
Acc Chem Res; 2017 Oct; 50(10):2510-2518. PubMed ID: 28953347
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Peptide Combination Can Hinder Resistance Evolution.
Maron B; Rolff J; Friedman J; Hayouka Z
Microbiol Spectr; 2022 Aug; 10(4):e0097322. PubMed ID: 35862981
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
[TBL] [Abstract][Full Text] [Related]
20. Esculentin-1a Derived Antipseudomonal Peptides: Limited Induction of Resistance and Synergy with Aztreonam.
Casciaro B; Loffredo MR; Luca V; Verrusio W; Cacciafesta M; Mangoni ML
Protein Pept Lett; 2018; 25(12):1155-1162. PubMed ID: 30381056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
